Focus on Immunology
We're constantly growing our expertise in Immunology so that we can continue to discover and develop innovative medicines for patients living with debilitating diseases, such as rheumatoid arthritis or asthma.
Our research and discovery efforts include aspects of both innate and adaptive immunity. The greater our understanding of basic mechanisms of immune cell function the more scientific opportunities arise to affect immune function for the treatment of autoimmune and oncologic indications.
Recent Accomplishments
-
Molecule: Anti-Factor D Fab
Anti-Factor D Fab is a humanized monoclonal antibody fragment targeting complement factor D. It is designed to inhibit complement activation and chronic inflammation in tissues. Complement Factor D is a member of the trypsin family of peptidases and is a component of the alternative complement pathway.
Pipeline
Genentech's Research and Early Development pipeline has over 25 new molecular entities in clinical development.
